Spinocerebellar ataxia type 3 (Machado-Joseph disease) and varenicline

被引：0
作者：
Young, Pablo [1 ]
Finn, Barbara C. [1 ]
Giuliani, Franco [1 ]
Reisin, Ricardo [2 ]
机构：
[1] Hosp Britan, Serv Clin Med, RA-1280 Buenos Aires, DF, Argentina
[2] Hosp Britan, Serv Neurol, RA-1280 Buenos Aires, DF, Argentina
来源：
REVISTA MEDICA DE CHILE | 2015年 / 143卷 / 09期
关键词：
RANDOMIZED-TRIAL; CHANTIX; DIAGNOSIS;
D O I：
10.4067/S0034-98872015000900019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1221 / 1222
页数：2
相关论文
共 10 条
  • [1] The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3′-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis
    Chatterjee, Arpita
    Saha, Saikat
    Chakraborty, Anirban
    Silva-Fernandes, Anabela
    Mandal, Santi M.
    Neves-Carvalho, Andreia
    Liu, Yongping
    Pandita, Raj K.
    Hegde, Muralidhar L.
    Hegde, Pavana M.
    Boldogh, Istvan
    Ashizawa, Tetsuo
    Koeppen, Arnulf H.
    Pandita, Tej K.
    Maciel, Patricia
    Sarkar, Partha S.
    Hazra, Tapas K.
    [J]. PLOS GENETICS, 2015, 11 (01):
  • [2] Connolly BS, 2012, NEUROLOGY, V79, P2218, DOI 10.1212/WNL.0b013e318278a059
  • [3] A RANDOMIZED TRIAL OF VARENICLINE (CHANTIX) FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 3
    Filla, Alessandro
    Sacca, Francesco
    De Michele, Giuseppe
    [J]. NEUROLOGY, 2012, 78 (19) : 1538 - 1538
  • [4] Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice
    Mendonca, Liliana S.
    Nobrega, Clevio
    Hirai, Hirokazu
    Kaspar, Brian K.
    de Almeida, Luis Pereira
    [J]. BRAIN, 2015, 138 : 320 - 335
  • [5] Diagnosis of Spinocerebellar Ataxia type 3 (Machado-Joseph disease) in Chile
    Miranda C, Marcelo
    [J]. REVISTA MEDICA DE CHILE, 2015, 143 (01) : 126 - 127
  • [6] A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript
    Ramani, Biswarathan
    Harris, Ginny M.
    Huang, Rogerio
    Seki, Takahiro
    Murphy, Geoffrey G.
    Costa, Maria do Carmo
    Fischer, Svetlana
    Saunders, Thomas L.
    Xia, Guangbin
    McEachin, Richard C.
    Paulson, Henry L.
    [J]. HUMAN MOLECULAR GENETICS, 2015, 24 (05) : 1211 - 1224
  • [7] Nerve Growth Factor for the Treatment of Spinocerebellar Ataxia Type 3: An Open-label Study
    Tan, Song
    Wang, Rui-Hao
    Niu, Hui-Xia
    Shi, Chang-He
    Mao, Cheng-Yuan
    Zhang, Rui
    Song, Bo
    Sun, Shi-Lei
    Liu, Xin-Jing
    Hou, Hai-Man
    Liu, Yu-Tao
    Gao, Yuan
    Fang, Hui
    Kong, Xiang-Dong
    Xu, Yu-Ming
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (03) : 291 - 294
  • [8] EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood
    van de Warrenburg, B. P. C.
    van Gaalen, J.
    Boesch, S.
    Burgunder, J. -M.
    Duerr, A.
    Giunti, P.
    Klockgether, T.
    Mariotti, C.
    Pandolfo, M.
    Riess, O.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (04) : 552 - 562
  • [9] Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia
    Wecker, L.
    Engberg, M. E.
    Philpot, R. M.
    Lambert, C. S.
    Kang, C. W.
    Antilla, J. C.
    Bickford, P. C.
    Hudson, C. E.
    Zesiewicz, T. A.
    Rowell, Peter P.
    [J]. NEUROPHARMACOLOGY, 2013, 73 : 75 - 86
  • [10] A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3
    Zesiewicz, T. A.
    Greenstein, P. E.
    Sullivan, K. L.
    Wecker, L.
    Miller, A.
    Jahan, I.
    Chen, R.
    Perlman, S. L.
    [J]. NEUROLOGY, 2012, 78 (08) : 545 - 550
1